Three paramagnetic CoIImacrocyclic complexes containing 2‐hydroxypropyl pendant groups, 1,1′,1′′,1′′′‐(1,4,8,11‐tetraazacyclotetradecane‐1,4,8,11‐tetrayl)tetrakis‐ (propan‐2‐ol) ([Co(L1)]2+, 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(propan‐2‐ol) ([Co(L2)]2+), and 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(octadecan‐2‐ol) ([Co(L3)]2+) were synthesized to prepare transition metal liposomal chemical exchange saturation transfer (lipoCEST) agents. In solution, ([Co(L1)]2+) forms two isomers as shown by1H NMR spectroscopy. X‐ray crystallographic studies show one isomer with 1,8‐pendants in
- Award ID(s):
- 2103637
- PAR ID:
- 10414940
- Date Published:
- Journal Name:
- Chemical Communications
- Volume:
- 58
- Issue:
- 66
- ISSN:
- 1359-7345
- Page Range / eLocation ID:
- 9258 to 9261
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
Abstract cis ‐configuration and a second isomer with 1,4‐pendants intrans ‐configuration. The [Co(L2)]2+complex has 1,8‐pendants in acis ‐configuration. Remarkably, the paramagnetic‐induced shift of water1H NMR resonances in the presence of the [Co(L1)]2+complex is as large as that observed for one of the most effective LnIIIwater proton shift agents. Incorporation of [Co(L1)]2+into the liposome aqueous core, followed by dialysis against a solution of 300 mOsm L−1produces a CEST peak at 3.5 ppm. Incorporation of the amphiphilic [Co(L3)]2+complex into the liposome bilayer produces a more highly shifted CEST peak at −13 ppm. Taken together, these data demonstrate the feasibility of preparing CoIIlipoCEST agents. -
Abstract Three paramagnetic CoIImacrocyclic complexes containing 2‐hydroxypropyl pendant groups, 1,1′,1′′,1′′′‐(1,4,8,11‐tetraazacyclotetradecane‐1,4,8,11‐tetrayl)tetrakis‐ (propan‐2‐ol) ([Co(L1)]2+, 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(propan‐2‐ol) ([Co(L2)]2+), and 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(octadecan‐2‐ol) ([Co(L3)]2+) were synthesized to prepare transition metal liposomal chemical exchange saturation transfer (lipoCEST) agents. In solution, ([Co(L1)]2+) forms two isomers as shown by1H NMR spectroscopy. X‐ray crystallographic studies show one isomer with 1,8‐pendants in
cis ‐configuration and a second isomer with 1,4‐pendants intrans ‐configuration. The [Co(L2)]2+complex has 1,8‐pendants in acis ‐configuration. Remarkably, the paramagnetic‐induced shift of water1H NMR resonances in the presence of the [Co(L1)]2+complex is as large as that observed for one of the most effective LnIIIwater proton shift agents. Incorporation of [Co(L1)]2+into the liposome aqueous core, followed by dialysis against a solution of 300 mOsm L−1produces a CEST peak at 3.5 ppm. Incorporation of the amphiphilic [Co(L3)]2+complex into the liposome bilayer produces a more highly shifted CEST peak at −13 ppm. Taken together, these data demonstrate the feasibility of preparing CoIIlipoCEST agents. -
At the beginning of the millennium, the first chemical exchange saturation transfer (CEST) contrast agents were bio‐organic molecules. However, later, metal‐based CEST agents (paraCEST agents) took center stage. This did not last too long as paraCEST agents showed limited translational potential. By contrast, the CEST field gradually became dominated by metal‐free CEST agents. One branch of research stemming from the original work by van Zijl and colleagues is the development of CEST agents based on polypeptides. Indeed, in the last 2 decades, tremendous progress has been achieved in this field. This includes the design of novel peptides as biosensors, genetically encoded recombinant as well as synthetic reporters. This was a result of extensive characterization and elucidation of the theoretical requirements for rational designing and engineering of such agents. Here, we provide an extensive overview of the evolution of more precise protein‐based CEST agents, review the rationalization of enzyme‐substrate pairs as CEST contrast enhancers, discuss the theoretical considerations to improve peptide selectivity, specificity and enhance CEST contrast. Moreover, we discuss the strong influence of synthetic biology on the development of the next generation of protein‐based CEST contrast agents.
-
Abstract Chemical exchange saturation transfer (CEST) MRI has been identified as a novel alternative to classical diagnostic imaging. Over the last several decades, many studies have been conducted to determine possible CEST agents, such as endogenously expressed compounds or proteins, that can be utilized to produce contrast with minimally invasive procedures and reduced or non‐existent levels of toxicity. In recent years there has been an increased interest in the generation of genetically engineered CEST contrast agents, typically based on existing proteins with CEST contrast or modified to produce CEST contrast. We have developed an in silico method for the evolution of peptide sequences to optimize CEST contrast and showed that these peptides could be combined to create de novo biosensors for CEST MRI. A single protein, superCESTide, was designed to be 198 amino acids. SuperCESTide was expressed in
and purified with size exclusion chromatography. The magnetic transfer ratio asymmetry generated by superCESTide was comparable to levels seen in previous CEST reporters, such as protamine sulfate (salmon protamine) and human protamine. These data show that novel peptides with sequences optimized in silico for CEST contrast that utilize a more comprehensive range of amino acids can still produce contrast when assembled into protein units expressed in complex living environments.E. coli